Beginning Cash: The amount of cash reported by the company on its previous statement.
CAMP4 Therapeutics Corporation (CAMP) had Beginning Cash of $65.66M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$3.50M |
|
$-80.40M |
|
-- |
|
$3.50M |
|
$56.05M |
|
$-52.55M |
|
$-27.85M |
|
$-80.40M |
|
$-80.40M |
|
$-80.40M |
|
$-80.40M |
|
$-80.40M |
|
$-80.40M |
|
$-52.55M |
|
$-50.92M |
|
30.38M |
|
30.38M |
|
$-2.65 |
|
$-2.65 |
|
| Balance Sheet Financials | |
$114.09M |
|
$2.34M |
|
$3.71M |
|
$117.81M |
|
$15.51M |
|
-- |
|
$54.59M |
|
$70.10M |
|
$47.70M |
|
$47.70M |
|
$47.70M |
|
51.90M |
|
| Cash Flow Statement Financials | |
$-29.55M |
|
$-0.24M |
|
$75.89M |
|
|
Beginning Cash |
$65.66M |
$111.76M |
|
$46.09M |
|
$4.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.35 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
100.00% |
|
-1502.43% |
|
-1502.43% |
|
-1455.57% |
|
-2298.54% |
|
-2298.54% |
|
$-29.80M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-168.55% |
|
-168.55% |
|
-68.25% |
|
-168.55% |
|
$0.92 |
|
$-0.98 |
|
$-0.97 |
|